Back to search

Article

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

2022-08-08

Abstract excerpt

Nirmatrelvir, an oral antiviral targeting the 3CL protease of SARS-CoV-2, has been demonstrated to be clinically useful in reducing hospitalization or death due to COVID-19 1,2 . However, as SARS-CoV-2 has evolved to become resistant to other therapeutic modalities 3–9 , there is a concern that the same could occur for nirmatrelvir. Here, we have examined this possibility by in vitro passaging of SARS-CoV-2 in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
61c4d618-74be-5fea-85c8-0ca5496616ef
DOI
10.1101/2022.08.07.499047
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvirDOI 10.1101/2022.08.07.499047
Select a neighboring publication to make it the new centre.